Skip to main content
Caplight Logo









Ketryx

Ketryx

Private
Cambridge, MassachusettsEnterprise Softwarehttps://www.ketryx.com/

Last Round

Series B

Sep 4, 2025

Total Funding Raised

$59.05M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ketryx is a software company that provides an AI-powered compliance platform designed to automate documentation, traceability, and validation for regulated medical device software development.

Sector

Enterprise Software

Verticals

Vertical SaaS, Compliance & Risk, Quality Management, RegTech

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

MedTech compliancequality management systemQMSRegTechsoftware development lifecycleSDLCAI complianceregulatory automationmedical device softwareFDA complianceAI agent securitydigital health softwareaudit-readycompliance automationALMapplication lifecycle management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ketryx Comparables

Compare Ketryx with similar companies based on industry and business-model similarity.

Ketryx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Greenlight Guru
83%
Matrix One
82%
Dot Compliance
78%

Ketryx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 4, 2025
Series ADec 5, 2023
SeedJul 6, 2022

Key People

Founding team and executive leadership

Jan Pöschko

CTO Founder

Founding Team

Ketryx Investors

Notable investors and investment history

Ketryx investors
InvestorRounds
GaingelsSeries B
Ubiquity VenturesSeries B, Seed, Series A
The E14 FundSeries B, Seed, Series A
53 StationsSeries B
Transformation CapitalSeries B
Leerink Transformation PartnersSeries B
Lightspeed Venture PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Powers 25% of the Fortune 500 MedTech market.

  • Apr 21, 2026

    Platform now touches the lives of 25 million patients.

Ketryx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ketryx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ketryx's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range142
Year Founded2021
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?